Finland· FI-REL-REL57844
CEVENFACTA
A coagulation factor viia product containing eptacog beta, registered in Finland by Laboratoire Francais du Fractionnement et des Biotechnologies. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Coagulation factor viia is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD08 (coagulation factor viia), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Coagulation factor viia · ATC B02BD08
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Eptacog beta
- Manufacturer
- Laboratoire Francais du Fractionnement et des Biotechnologies
- Country
- Finland (FI)
- ATC code
- B02BD08
- ATC class
- Coagulation factor VIIa
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for coagulation factor viia.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Coagulation factor viia · interactions on record
5 records
- 2 severe
- 2 moderate
- 1 minor
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03moderate
- EmicizumabB02BX06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B02BD08
Coagulation factor viia, as other registers publish it.
- IcelandCevenfactaLaboratoire français du Fractionnement et des Biotechnologies
- PolandCevenfactaLaboratoire français du Fractionnement et des Biotechnologies
- IcelandCevenfactaLaboratoire français du Fractionnement et des Biotechnologies
- PolandCevenfactaLaboratoire français du Fractionnement et des Biotechnologies
- IcelandCevenfactaLaboratoire français du Fractionnement et des Biotechnologies
- PolandCevenfactaLaboratoire français du Fractionnement et des Biotechnologies
- FinlandCEVENFACTALaboratoire Francais du Fractionnement et des Biotechnologies
- CzechiaCEVENFACTALaboratoire Français du Fractionnement et des Biotechnologies, Puteaux
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc981874-7ec9-420e-b274-8b0b7ff744da GET /v1/drugs/bc981874-7ec9-420e-b274-8b0b7ff744da?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektiokuiva-aine ja liuotin, liuosta varten",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "2 mg (90 KIU)",
"atc_label": "hyytymistekijä VIIa",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/22/1664/002",
"fimea_rel_id": "REL57844",
"authorised_at": "2022-07-15"
}See everything about coagulation factor viia.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.